Drug-Induced Hepatotoxicity And Protection

Researchers investigate the adverse effects of medications and other xenobiotics on liver function. This work involves identifying the molecular mechanisms by which drugs cause liver damage, including oxidative stress, inflammation, and cellular death pathways. Studies utilize various *in vitro* and *in vivo* models to assess drug metabolism, predict potential toxicities, and evaluate protective strategies. Areas of focus include the development of novel biomarkers for early detection of liver injury and the exploration of therapeutic interventions to mitigate or reverse drug-induced hepatotoxicity.

This research is pertinent to Arkansas’s public health landscape, particularly concerning the safe and effective use of pharmaceuticals within diverse patient populations. Understanding drug-induced liver injury is crucial for healthcare providers and pharmaceutical developers, impacting patient outcomes and the state’s healthcare system. Furthermore, investigations into environmental toxicants and their impact on liver health can inform public health initiatives and regulatory policies relevant to the state.

This field draws upon expertise in pharmacology, toxicology, molecular biology, and immunology. Engagement spans multiple Arkansas institutions, fostering collaboration across academic disciplines and contributing to a robust research ecosystem within the state.